8257 — Genes Tech group Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$56.00m
- HK$172.59m
- TWD1.33bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 260 | 197 | 118 | -82.4 | 126 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 42.6 | 17.3 | 56.6 | 269 | 14.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -467 | -188 | 36.5 | -146 | -194 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -137 | 63.6 | 254 | 82.5 | -11.2 |
Capital Expenditures | -58.6 | -37.5 | -5.29 | -18.1 | -12 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -214 | 0.135 | 0.1 | 0.438 | 1.06 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -273 | -37.4 | -5.19 | -17.6 | -10.9 |
Financing Cash Flow Items | -15.1 | -13.6 | -12.2 | -13.8 | -18.7 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 269 | -63.8 | -171 | -11.4 | -66.6 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -145 | -41.1 | 76.7 | 66.7 | -88.9 |